Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Could Moderna and AstraZeneca's mRNA Heart Failure Drug Candidate Be a Winner?
Could Moderna and AstraZeneca's mRNA Heart Failure Drug Candidate Be a Winner?
Could Moderna and AstraZeneca's mRNA Heart Failure Drug Candidate Be a Winner?
Submitted by
admin
on December 5, 2021 - 10:47pm
Source:
Motley Fool
News Tags:
Moderna Therapeutics
AstraZeneca
AZD-8601
heart failure
MRNA
Headline:
Could Moderna and AstraZeneca's mRNA Heart Failure Drug Candidate Be a Winner?
snippet:
Moderna and AstraZeneca reported positive results from a phase 2 study of AZD-8601.
The mRNA heart failure drug appears to be promising.
However, the clinical development of AZD-8601 will likely take a long time.
Do Not Allow Advertisers to Use My Personal information
